A Phase (Ph) III clinical program: 1L atezolizumab (atezo) plus chemotherapy (chemo) in chemo-naive advanced NSCLC

Category Primary study
JournalAnnals of Oncology
Year 2016
This article has no abstract
Epistemonikos ID: d440b454582ed4b40e71d493d5790c8e1a668bc8
First added on: Feb 08, 2025